Lipocine Inc
NASDAQ:LPCN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lipocine Inc
NASDAQ:LPCN
|
US |
|
Clarke Inc
F:CK5A
|
CA |
|
S
|
Swiss Life Holding AG
XHAM:SLW
|
CH |
|
C
|
Cushman & Wakefield PLC
SWB:2IY
|
UK |
|
Orrstown Financial Services Inc
F:OFR
|
US |
|
A
|
Aurubis AG
XMUN:NDA
|
DE |
|
A
|
Aedifica NV
SWB:AOO
|
BE |
|
S
|
Smurfit Kappa Group PLC
XMUN:SK3
|
IE |
|
Dow Inc
NYSE:DOW
|
US |
|
B
|
Banco de Sabadell SA
XBER:BDSB
|
ES |
|
D
|
DXC Technology Co
F:2XT
|
US |
|
V
|
Ventas Inc
F:VEN
|
US |
|
G
|
GM Leather SpA
MIL:GML
|
IT |
|
R
|
RTL Group SA
DUS:RRTL
|
LU |
|
T
|
TFI International Inc
F:9TF
|
CA |
|
A
|
AT&T Inc
DUS:SOBA
|
US |
|
S
|
Swiss Re AG
F:SR9
|
CH |
|
Vitesco Technologies Group AG
F:VTSC
|
DE |
|
J
|
Jervois Global Ltd
SWB:IHS
|
AU |
|
Powszechny Zaklad Ubezpieczen SA
F:7PZ0
|
PL |
|
Enact Holdings Inc
NASDAQ:ACT
|
US |
Bankruptcy Probability
Lipocine Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lipocine Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Lipocine Inc
NASDAQ:LPCN
|
19.9m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
618.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Hisamitsu Pharmaceutical Co Inc
TSE:4530
|
70.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
305.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
237.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
199.1B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
243.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
289B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lipocine Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lipocine Inc has no debt.
You can find a full breakdown on its Balance Sheet.
